Pediatric cost-benefit analysis

被引:0
|
作者
Schulze-Gattermann, H
Illg, A
Lesinski-Schiedat, A
Schoenermark, M
Bertram, B
Lenarz, T
机构
[1] Drager Med AG & Co KGaA, Lubeck, Germany
[2] Hannover Med Sch, Hals Nasen Ohren Klin, Hannover, Germany
[3] Hannover Sch Hlth Management, Hannover, Germany
[4] Cochlear Implant Ctr Wilhelm Hirte, Hannover, Germany
关键词
cochlear implantation (pediatric); cost-benefit analysis; hearing aid usage; prelingually deafened children; educational setting; societal/payers' perspective;
D O I
暂无
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Background: The aim of this study was to explore the cost-benefit-ratio of pediatric cochlear implantation for congenitally deaf and prelingually deafened children compared to children with hearing aids. The payers' perspective was chosen as this is the most relevant for cost discussions. The study should verify the hypothesis that educational and associated full costs increase with the age at implantation and that these can be below costs for children with hearing aids. Methods: Children implanted at different ages (group 1: 0 - 1.9 yr., group 2: 2 - 3.9 yr., group 3: 4 - 6.9 yr.) were compared with deaf children using hearing aids (group 4). Payers were sick funds and public authorities, the first paying for medical and indirect costs, the latter paying for education. Educational settings were used as measure for benefit. All costs related to the hearing deficiency were included up to the age of 16 years (end of primary education) based on 1999 costs. Results: Discounted medical and indirect costs for a pediatric cochlear implant user varied between DM 112,000 ($ 53,300) and DM 91,000 ($ 43,300) depending on the age at implantation. Costs for a hearing aid user added up to DM 36,000 ($ 17,100). These costs were paid by the sick funds. Costs for education varied between DM 159,000 ($ 75,700) for group 1 and DM 257,000 ($ 122,400) for group 3 compared to DM 277,000 ($ 131,900) for hearing aid users. These differences are mainly based on the use of mainstream schools. Total costs for sick funds and public authorities ad up to DM 271,000 ($ 129,000), DM 334,000 ($ 159,000) and DM 348,000 ($ 165,700), respectively, for the three age groups of implanted children compared to DM 313,000 ($148,600) for hearing aid users. Conclusion: This study supports the view that pediatric cochlear implantation provides positive cost-benefit ratios compared to hearing aid users depending on the age at implantation. From a societal/payer perspective implantation of prelingually deafened children is especially recommended for children under the age of 2 years. Implantation between ages 2 and 3,9 can be recommended from an educational perspective. Implantation at ages >7 years must be based on individual decisions considering psychosocial environment, speech and language status and type of communication.
引用
收藏
页码:322 / 329
页数:8
相关论文
共 50 条
  • [1] Cost-benefit analysis
    Miura, Grant
    [J]. NATURE CHEMICAL BIOLOGY, 2018, 14 (10) : 903 - 903
  • [2] COST-BENEFIT ANALYSIS
    BJORNSTAD, P
    [J]. KJEMI, 1975, 35 (10): : 3 - 3
  • [3] Cost-benefit analysis of pediatric cochlear implantation: German experience
    Schulze-Gattermann, H
    Illg, A
    Schoenermark, M
    Lenarz, T
    Lesinski-Schiedat, A
    [J]. OTOLOGY & NEUROTOLOGY, 2002, 23 (05) : 674 - 681
  • [4] Cost-utility and cost-benefit analysis of pediatric PCV programs in Egypt
    Sevilla, J. P.
    Burnes, Daria
    El Saie, Rehab Zakaria
    Haridy, Hammam
    Wasserman, Matt
    Pugh, Sarah
    Perdrizet, Johnna
    Bloom, David
    [J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2022, 18 (06)
  • [5] The Cost-Benefit Fallacy: Why Cost-Benefit Analysis Is Broken and How to Fix It
    Flyvbjerg, Bent
    Bester, Dirk W.
    [J]. JOURNAL OF BENEFIT-COST ANALYSIS, 2021, 12 (03) : 395 - 419
  • [6] Incommensurability and cost-benefit analysis
    Adler, M
    [J]. UNIVERSITY OF PENNSYLVANIA LAW REVIEW, 1998, 146 (05) : 1371 - 1418
  • [7] Cost-Benefit Analysis in Reasoning
    Alaoui, Larbi
    Penta, Antonio
    [J]. JOURNAL OF POLITICAL ECONOMY, 2022, : 881 - 925
  • [8] Beware the cost-benefit analysis
    Spence, Des
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2012, 345
  • [9] In Defence of Cost-Benefit Analysis
    Ergas, Henry
    [J]. AGENDA-A JOURNAL OF POLICY ANALYSIS AND REFORM, 2009, 16 (03) : 31 - 40
  • [10] Humanizing Cost-Benefit Analysis
    Sunstein, Cass R.
    [J]. EUROPEAN JOURNAL OF RISK REGULATION, 2011, 2 (01) : 3 - 7